Cargando…
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial
BACKGROUND: Supporting well-informed decisions about breast cancer screening requires communicating that inconsequential disease may be detected, leading to overdiagnosis and overtreatment. Having previously shown that telling women about overdetection improved informed choice, we investigated effec...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562961/ https://www.ncbi.nlm.nih.gov/pubmed/33871631 http://dx.doi.org/10.1093/jnci/djab083 |
_version_ | 1784593336480301056 |
---|---|
author | Hersch, Jolyn Barratt, Alexandra McGeechan, Kevin Jansen, Jesse Houssami, Nehmat Dhillon, Haryana Jacklyn, Gemma Irwig, Les McCaffery, Kirsten |
author_facet | Hersch, Jolyn Barratt, Alexandra McGeechan, Kevin Jansen, Jesse Houssami, Nehmat Dhillon, Haryana Jacklyn, Gemma Irwig, Les McCaffery, Kirsten |
author_sort | Hersch, Jolyn |
collection | PubMed |
description | BACKGROUND: Supporting well-informed decisions about breast cancer screening requires communicating that inconsequential disease may be detected, leading to overdiagnosis and overtreatment. Having previously shown that telling women about overdetection improved informed choice, we investigated effects on screening knowledge and participation over 2 years. METHODS: We conducted a community-based, parallel-group, randomized controlled trial in Australia. Participants were women aged 48-50 years, without personal or strong family history of breast cancer, who had not undergone mammography in the past 2 years. We randomly assigned 879 women to receive the intervention decision aid (evidence-based information on overdetection, breast cancer mortality reduction, and false-positives) or control decision aid (identical but without overdetection information). We interviewed 838 women postintervention and recontacted them for follow-up at 6 months and 1 and 2 years. Main outcomes for this report are screening knowledge and participation. RESULTS: We interviewed 790, 746, and 712 participants at 6 months, 1, and 2 years, respectively. The intervention group demonstrated superior knowledge throughout follow-up. After 2 years, conceptual knowledge was adequate in 123 (34.4%) of 358 women in the intervention group compared with 71 (20.1%) of 354 control participants(odds ratio = 2.04, 95% confidence interval = 1.46 to 2.85). Groups were similar in total screening participation (200 [55.1%] vs 204 [56.0%]; = 0.97, 95% confidence interval = 0.73 to 1.29). CONCLUSIONS: A brief decision aid produced lasting improvement in women’s understanding of potential consequences of screening, including overdetection, without changing participation rates. These findings support the use of decision aids for breast cancer screening. |
format | Online Article Text |
id | pubmed-8562961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-85629612021-11-03 Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial Hersch, Jolyn Barratt, Alexandra McGeechan, Kevin Jansen, Jesse Houssami, Nehmat Dhillon, Haryana Jacklyn, Gemma Irwig, Les McCaffery, Kirsten J Natl Cancer Inst Articles BACKGROUND: Supporting well-informed decisions about breast cancer screening requires communicating that inconsequential disease may be detected, leading to overdiagnosis and overtreatment. Having previously shown that telling women about overdetection improved informed choice, we investigated effects on screening knowledge and participation over 2 years. METHODS: We conducted a community-based, parallel-group, randomized controlled trial in Australia. Participants were women aged 48-50 years, without personal or strong family history of breast cancer, who had not undergone mammography in the past 2 years. We randomly assigned 879 women to receive the intervention decision aid (evidence-based information on overdetection, breast cancer mortality reduction, and false-positives) or control decision aid (identical but without overdetection information). We interviewed 838 women postintervention and recontacted them for follow-up at 6 months and 1 and 2 years. Main outcomes for this report are screening knowledge and participation. RESULTS: We interviewed 790, 746, and 712 participants at 6 months, 1, and 2 years, respectively. The intervention group demonstrated superior knowledge throughout follow-up. After 2 years, conceptual knowledge was adequate in 123 (34.4%) of 358 women in the intervention group compared with 71 (20.1%) of 354 control participants(odds ratio = 2.04, 95% confidence interval = 1.46 to 2.85). Groups were similar in total screening participation (200 [55.1%] vs 204 [56.0%]; = 0.97, 95% confidence interval = 0.73 to 1.29). CONCLUSIONS: A brief decision aid produced lasting improvement in women’s understanding of potential consequences of screening, including overdetection, without changing participation rates. These findings support the use of decision aids for breast cancer screening. Oxford University Press 2021-04-19 /pmc/articles/PMC8562961/ /pubmed/33871631 http://dx.doi.org/10.1093/jnci/djab083 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Articles Hersch, Jolyn Barratt, Alexandra McGeechan, Kevin Jansen, Jesse Houssami, Nehmat Dhillon, Haryana Jacklyn, Gemma Irwig, Les McCaffery, Kirsten Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial |
title | Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial |
title_full | Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial |
title_fullStr | Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial |
title_full_unstemmed | Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial |
title_short | Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial |
title_sort | informing women about overdetection in breast cancer screening: two-year outcomes from a randomized trial |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562961/ https://www.ncbi.nlm.nih.gov/pubmed/33871631 http://dx.doi.org/10.1093/jnci/djab083 |
work_keys_str_mv | AT herschjolyn informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT barrattalexandra informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT mcgeechankevin informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT jansenjesse informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT houssaminehmat informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT dhillonharyana informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT jacklyngemma informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT irwigles informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial AT mccafferykirsten informingwomenaboutoverdetectioninbreastcancerscreeningtwoyearoutcomesfromarandomizedtrial |